Skip to main
HSIC

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 8%
Buy 42%
Hold 42%
Sell 8%
Strong Sell 0%

Bulls say

Henry Schein is a trusted and established company in the healthcare industry, with a global presence and strong customer satisfaction focus. Its leadership in the dental market and strategy for sustainable earnings growth make it a positive investment option, although it does face competition and potential risks such as cyber attacks. The company's recent financial results have been better than expected and the announcement of a new CEO with M&A experience could lead to further growth opportunities. Opinions are mixed on the potential impact of healthcare laws on the company, but its strong brand and potential for growth make it a favorable stock in the healthcare sector. Other companies in the industry have varying ratings and price targets.

Bears say

Henry Schein is facing risks related to their growth and competition in the industry, along with potential risks associated with their expansion into software services and potential changes in healthcare legislation. However, the company has a clear M&A strategy focused on high-growth and high-margin businesses, with a strong focus on margins and growth. The new Chief Strategic Officer, with a background in M&A, is expected to play a significant role in driving the company's global strategic planning, and HSIC expects at least 50% of their future operating income to come from these high-growth segments.

Henry Schein (HSIC) has been analyzed by 12 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 42% recommend Buy, 42% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Hold based on their latest research and market trends.

According to 12 analysts, Henry Schein (HSIC) has a Hold consensus rating as of May 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $87.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $87.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.